GLP-1 Peptide Atlas, by Delfa

← Trials/Trial dossier/NCT01988545

UnknownPhase NA

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

GLP-1's Influence on Intestinal Blood Flow

Lead sponsor

Zealand University Hospital

Asset

Exenatide

GLP-1 agonist

Listed sites

Recruiting sites

Enrollment

estimated

Study population

Healthy volunteers

Key I/E criterion

•Healthy volunteers

Primary endpoint

•Blood flow

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT01988545

Org study ID2013.GLP-1

Timeline

Milestones

Study first posted2013-11-20estimated

Last update posted2013-11-20estimated

Study start2013-11 (month precision)

Primary completion2014-06estimated (month precision)

Study completion2014-12estimated (month precision)

Assets

Investigational agents

Exenatide

Study populations

Who this study enrolls

Healthy volunteers

Eligibility

Who can enroll

Minimum age20 Years

Maximum age80 Years

SexAll

Healthy volunteersAccepted

Inclusion criteria

•healthy subjects

Exclusion criteria

•medical conditions

Endpoints (2)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other (unclassified)

2 endpoints

Primary/protocol endpoint/low confidence

blood flow

Time frame:with in 120 minutes

change from baseline, descriptive

Other/protocol endpoint/low confidence

cardiac parameters

Time frame:with in 120 minutes

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 1, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.